OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutical Sciences is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	217
In vitro identification of decreased function genetic variants of ABCB1	181
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	176
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	126
Editorial Board	124
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	117
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	107
Esomeprazole prevents oxaliplatin-induced peripheral neuropathy through inhibiting organic cation transporter 2 in mice	106
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia	90
Development and optimization of Soluplus®/Pluronic-based polymeric micelles for bicalutamide delivery: characterization, lyophilization, stability, and cellular studies	70
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	66
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies	59
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	56
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	54
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	53
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	53
Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism	52
Impact of protein adsorption during biopharmaceutical manufacture & storage	52
Opportunities of topical drug products in a changing dermatological landscape	52
Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols	50
Application of a forward design-based multi-attribute decision-making method in quality assessment in pharmaceutical tablet manufacturing	49
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	48
3D printed extended-release hydrochlorothiazide tablets	45
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	45
The effect of formulation composition and flow conditions on the robustness of semisolid extrusion 3D printing: a case study on poorly water-soluble itraconazole for oral dosage form production	41

Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	40
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation	39
Nitrite testing in excipients – Industry best practices	39
Surrogate-based LC–MS/MS quantification of endogenous creatinine in plasma, plasma-equivalent dried spots (qDPS), and volumetric absorptive microsampling (VAMS): an ICH M10-compliant bridging study	38
FOSL1 mediates collagen synthesis and myofibroblast transformation in aortic fibroblasts under Ang II-induced aortic dissection conditions	38
In Vitro Investigation of Tapinarof-Loaded Nanogels in an Imiquimod-induced HaCaT–THP-1 Co-Culture Model	38
Microparticles and multi-unit systems for advanced drug delivery	38
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach	37
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation	37
Controlled release and extended pulmonary retention of inhaled therapeutics: A review	36
Towards optimization of dexamethasone therapy in the maintenance phase of pediatric acute lymphoblastic leukemia: A population pharmacokinetic and pharmacodynamic study of dexamethasone and metabolite	36
Virtual special issue of Nordic POP: Patient-oriented products	36